Women with ongoing urinary incontinence could avoid invasive bladder pressure tests, as new research shows that a range of ...
New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that a new diagnosis of type 2 diabetes is linked to a subsequent increase in the ...
Under the agreement, Rhythm has agreed to repay $6.3 million in cash to RareStone. Rhythm also agreed to return all shares of RareStone that were acquired under the original agreement for no ...
Opinion
5dOpinion
The Bolton News on MSN'Parents need to take the lead in the fight against childhood obesity'Childhood obesity is a pandemic that continues to threaten the health of children in the UK, despite several calls for action over the years.
Setmelanotide is a melanocortin-4 receptor (MC4R) agonist designed to treat hyperphagia and obesity. Rhythm is evaluating setmelanotide in a global Phase 3 trial in patients with acquired hypothalamic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results